enloplatin

structure given in first source

Also Known As:

(1,1-cyclobutanedicarboxylato(2-)-O,O')(tetrahydro-4H-pyran-4,4-dimethanamine-N,N')platinum(II); CL 287110; CL-287110

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Ovarian Neoplasms (Ovarian Cancer) 08/01/1997 - "This was a study of enloplatin in 18 evaluable patients with platinum refractory ovarian cancer. "
2.	Carcinoma (Carcinomatosis) 08/01/1997 - "A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma."

1.	Platinum